NIPH Clinical Trials Search

A nutrition care support and efficacy of Levocarnitine Chloride(We change it to Levocarnitine from May 15,2015) in patients with NAFLD patients

Basic Information

Recruitment status	Open public recruiting
Health condition(s) or Problem(s) studied	NAFLD
Date of first enrollment	2014/02/05
Target sample size	50
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	The follow-up by the nutrition education 3 months Levocarnitine Chloride at a600mg(We change it to Levocarnitine at a500mg from May 15,2015) thrice daily for 6 months

Outcome(s)

Primary Outcome	hematologic biochemical test (AST･ALT･gamma-GTP･TC･LDL･TG･FBS･UA･insulin･IRI･Fe･Ferritin) Body fat measurement using CT physical measurement body component analysis(In Body)
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Male and Female
Include criteria	The patients who had a diagnosis of NAFLD by liver biopsy with using echo guide in this hospital
Exclude criteria	Pacemaker wearing The metal patients who enter who we have history of bone fracture, and are artificial